Authors: Kosmidis, P Mylonakis, N Skarlos, D Samantas, E Dimopoulos, M Papadimitriou, C Kalophonos, C Pavlidis, N Nikolaidis, C Papaconstantinou, C Fountzilas, G

Citation: P. Kosmidis et al., Paclitaxel (175 mg/m(2)) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m(2))plus carboplatin (6 AUG) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial, ANN ONCOL, 11(7), 2000, pp. 799-805

Authors: Samantas, E Kalofonos, H Linardou, H Nicolaides, C Mylonakis, N Fountzilas, G Kosmidis, P Skarlos, D

Citation: E. Samantas et al., Phase II study of pegylated liposomal doxorubicin: Inactive in recurrent small-cell lung cancer - A Hellenic Cooperative Oncology Group Study, ANN ONCOL, 11(11), 2000, pp. 1395-1397

Authors: Tsavaris, N Kosmas, C Mylonakis, N Bacoyiannis, C Kalergis, G Vadiaka, M Boulamatsis, D Iakovidis, V Kosmidis, P

Citation: N. Tsavaris et al., Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy, ANTICANC R, 20(6C), 2000, pp. 4777-4783

Authors: Kosmidis, P Mylonakis, N Dimopoulos, A Pavlidis, N Fountzilas, G Samantas, E Dimitriadis, K Kalophonos, C Tsavdaridis, D Skarlos, D

Citation: P. Kosmidis et al., Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: A phase III randomized study. Preliminary results, SEMIN ONCOL, 27(1), 2000, pp. 3-8

Authors: Samantas, E Skarlos, DV Pectasides, D Nicolaides, P Kalofonos, H Mylonakis, N Vardoulakis, T Kosmidis, P Pavlidis, N Fountzilas, G

Citation: E. Samantas et al., Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer, LUNG CANC, 23(2), 1999, pp. 159-168